Pacira BioSciences, Inc. (PCRX)

Nasdaq Health Care Pharmaceuticals S&P SmallCap 600

$36.43

+0.01 (+0.03%)

Close of Nov 06, 2026 · end-of-day data

Source: Pacira BioSciences, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$270.07M	$284.34M	$332.43M	$418.93M	$429.65M	$541.53M	$666.82M	$674.98M	$700.97M	$726.41M
Cost of revenue	$110.10M	$87.92M	$86.84M	$106.71M	$117.33M	$140.25M	$199.29M	$184.67M	$170.43M	$149.75M
Gross profit	$159.97M	$196.43M	$245.58M	$312.21M	$312.32M	$401.28M	$467.53M	$490.31M	$530.54M	$576.66M
Research & development	$45.68M	$57.29M	$55.69M	$72.12M	$59.42M	$55.55M	$84.80M	$76.26M	$81.58M	$117.31M
Selling, general & admin	$152.61M	$161.49M	$177.26M	$200.78M	$193.52M	$199.34M	$254.52M	$269.44M	$294.10M	$368.76M
Operating income	-$32.02M	-$24.94M	$15.91M	$10.48M	$46.35M	$89.92M	$60.02M	$87.67M	-$73.37M	$19.19M
Interest expense	$7.06M	$18.05M	$21.95M	$23.63M	$25.67M	$31.75M	$39.98M	$20.31M	$16.57M	$17.45M
Pre-tax income	-$37.84M	-$42.47M	-$425.00K	-$10.75M	$20.09M	$56.40M	$13.30M	$61.70M	-$63.11M	$16.87M
Income tax	$105.00K	$140.00K	$46.00K	$268.00K	-$125.43M	$14.42M	-$2.61M	$19.75M	$36.45M	$9.84M
Net income	-$37.95M	-$42.61M	-$471.00K	-$11.02M	$145.52M	$41.98M	$15.91M	$41.95M	-$99.56M	$7.03M
EBITDA	-$19.11M	-$11.10M	$29.08M	$30.06M	$66.26M	$118.47M	$151.53M	$163.25M	$5.41M	$110.21M
EPS (basic)	$-1.02	$-1.07	$-0.01	$-0.27	$3.41	$0.95	$0.35	$0.91	$-2.15	$0.16
EPS (diluted)	$-1.02	$-1.07	$-0.01	$-0.27	$3.33	$0.92	$0.34	$0.89	$-2.15	$0.16
Diluted shares	37.24M	39.81M	40.91M	41.51M	43.68M	45.63M	46.54M	51.98M	46.24M	45.04M
Gross margin	59.2%	69.1%	73.9%	74.5%	72.7%	74.1%	70.1%	72.6%	75.7%	79.4%
Operating margin	-11.9%	-8.8%	4.8%	2.5%	10.8%	16.6%	9.0%	13.0%	-10.5%	2.6%
Net margin	-14.1%	-15.0%	-0.1%	-2.6%	33.9%	7.8%	2.4%	6.2%	-14.2%	1.0%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$35.94M	$54.13M	$132.53M	$78.23M	$99.96M	$585.58M	$104.14M	$153.30M	$276.77M	$158.54M
Short-term investments	$136.65M	$257.22M	$250.93M	$213.72M	$421.70M	$70.83M	$184.51M	$125.28M	$207.84M	$79.88M
Receivables	$29.94M	$31.66M	$38.00M	$47.53M	$53.05M	$96.32M	$98.40M	$105.56M	$113.30M	$124.07M
Inventory	$31.28M	$41.41M	$48.57M	$58.30M	$64.65M	$98.55M	$96.06M	$104.35M	$125.28M	$152.86M
Total current assets	$243.09M	$391.11M	$477.97M	$408.56M	$651.62M	$866.05M	$498.33M	$509.99M	$745.13M	$547.97M
Goodwill	$46.74M	$55.20M	$62.04M	$99.55M	$99.55M	$145.20M	$163.24M	$163.24M	$0	$20.21M
Total assets	$391.47M	$628.37M	$689.35M	$831.07M	$1.27B	$2.08B	$1.68B	$1.57B	$1.55B	$1.26B
Total current liabilities	$44.84M	$56.22M	$60.66M	$107.67M	$253.33M	$521.12M	$147.77M	$97.38M	$309.92M	$120.59M
Short-term debt	$118.53M	—	—	—	—	—	—	—	$201.78M	$0
Long-term debt	$108.74M	—	—	—	—	—	$689.47M	$522.44M	$383.55M	$372.19M
Total debt	$227.27M	—	—	—	—	—	$689.47M	$522.44M	$585.32M	$372.19M
Total liabilities	$172.49M	$348.89M	$368.13M	$476.12M	$654.83M	$1.34B	$906.19M	$704.26M	$775.17M	$571.81M
Shareholders' equity	$218.98M	$279.48M	$321.23M	$354.94M	$619.69M	$730.41M	$775.01M	$870.13M	$778.35M	$693.11M

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$33.45M	$17.79M	$48.87M	$70.52M	$77.03M	$125.72M	$145.27M	$154.65M	$189.39M	$151.99M
Capital expenditures	$24.71M	$19.27M	$14.51M	$10.16M	$37.80M	$45.87M	$30.08M	$15.16M	$10.64M	$15.33M
Free cash flow	$8.74M	-$1.48M	$34.36M	$60.36M	$39.23M	$79.85M	$115.20M	$139.49M	$178.75M	$136.66M
Investing cash flow	-$61.75M	-$223.76M	$20.58M	-$128.49M	-$277.61M	-$20.79M	-$225.19M	$77.54M	-$83.28M	$99.48M
Financing cash flow	$7.26M	$224.16M	$8.95M	$3.67M	$222.30M	$380.69M	-$401.53M	-$183.03M	$17.36M	-$369.63M
Share buybacks	—	—	—	—	—	—	$0	$0	$25.00M	$148.33M
Stock-based compensation	$31.25M	$31.60M	$31.73M	$33.65M	$39.92M	$42.25M	$48.09M	$47.90M	$51.17M	$57.50M
Depreciation & amortization	$12.92M	$13.83M	$13.16M	$19.58M	$19.91M	$28.55M	$91.50M	$75.57M	$78.78M	$91.02M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$181.24M	$167.12M	$178.02M	$168.57M	$187.25M	$168.92M	$181.10M	$179.52M	$196.87M	$177.38M	$192.40M	$176.65M
Cost of revenue	$47.69M	$47.42M	$44.26M	$38.86M	$39.89M	$34.31M	$40.87M	$34.28M	$40.30M	$36.41M	$44.16M	$37.23M
Gross profit	$133.55M	$119.70M	$133.76M	$129.71M	$147.37M	$134.62M	$140.23M	$145.24M	$156.57M	$140.96M	$148.24M	$139.42M
Research & development	$19.46M	$18.24M	$20.34M	$19.10M	$23.90M	$25.34M	$28.20M	$25.97M	$37.45M	$28.07M	$30.24M	$26.68M
Selling, general & admin	$65.80M	$72.03M	$68.13M	$74.33M	$79.61M	$86.78M	$88.58M	$91.80M	$101.61M	$93.94M	$91.81M	$83.84M
Operating income	$33.17M	$13.21M	$28.24M	-$139.53M	$24.70M	$1.99M	$8.50M	$6.36M	$2.34M	$6.90M	$4.27M	$22.27M
Interest expense	$3.39M	$3.32M	$3.88M	$4.69M	$4.68M	$4.58M	$4.70M	$4.28M	$3.89M	$3.70M	$3.62M	$2.88M
Pre-tax income	$33.72M	$13.64M	$36.58M	-$138.86M	$25.53M	$8.71M	-$1.93M	$9.52M	$571.00K	$5.00M	$2.56M	$28.81M
Income tax	$8.85M	$4.66M	$17.70M	$4.61M	$9.48M	$3.89M	$2.92M	$4.09M	-$1.07M	$2.08M	-$2.10M	$293.00K
Net income	$24.87M	$8.98M	$18.89M	-$143.47M	$16.04M	$4.81M	-$4.85M	$5.43M	$1.64M	$2.92M	$4.65M	$28.52M
EBITDA	$51.65M	$31.64M	$47.10M	-$119.27M	$45.95M	$23.16M	$35.82M	$27.55M	$23.68M	$28.23M	$25.56M	$41.54M
EPS (basic)	$0.54	$0.19	$0.41	$-3.11	$0.35	$0.10	$-0.11	$0.12	$0.04	$0.07	$0.12	$0.72
EPS (diluted)	$0.52	$0.19	$0.39	$-3.11	$0.35	$0.10	$-0.11	$0.12	$0.04	$0.07	$0.12	$0.70
Diluted shares	5.64M	52.19M	50.54M	46.13M	-24.00K	46.53M	45.46M	44.46M	-687.00K	40.91M	40.30M	40.83M
Gross margin	73.7%	71.6%	75.1%	76.9%	78.7%	79.7%	77.4%	80.9%	79.5%	79.5%	77.0%	78.9%
Operating margin	18.3%	7.9%	15.9%	-82.8%	13.2%	1.2%	4.7%	3.5%	1.2%	3.9%	2.2%	12.6%
Net margin	13.7%	5.4%	10.6%	-85.1%	8.6%	2.8%	-2.7%	3.0%	0.8%	1.6%	2.4%	16.1%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$153.30M	$184.05M	$247.05M	$245.97M	$276.77M	$283.61M	$300.48M	$147.59M	$158.54M	$144.31M	$205.88M	$246.96M
Short-term investments	$125.28M	$141.84M	$157.17M	$207.84M	$207.84M	$210.02M	$145.38M	$98.75M	$79.88M	$57.87M	$45.16M	$48.62M
Receivables	$105.56M	$101.64M	$104.78M	$100.65M	$113.30M	$104.75M	$114.37M	$115.27M	$124.07M	$125.64M	$132.42M	$122.89M
Inventory	$104.35M	$96.78M	$103.44M	$111.86M	$125.28M	$133.75M	$148.16M	$157.68M	$152.86M	$150.37M	$134.57M	$129.49M
Total current assets	$509.99M	$543.11M	$632.21M	$689.97M	$745.13M	$759.96M	$745.61M	$562.75M	$547.97M	$514.96M	$615.22M	$590.23M
Goodwill	$163.24M	$163.24M	$163.24M	$0	$0	$21.52M	$20.30M	$20.32M	$20.21M	$19.77M	$19.64M	$19.54M
Total assets	$1.57B	$1.58B	$1.65B	$1.52B	$1.55B	$1.59B	$1.54B	$1.30B	$1.26B	$1.21B	$1.24B	$1.20B
Total current liabilities	$97.38M	$93.44M	$92.69M	$306.40M	$309.92M	$314.73M	$313.16M	$107.08M	$120.59M	$108.79M	$122.01M	$126.10M
Short-term debt	—	—	—	—	$201.78M	—	—	$0	$0	—	—	—
Long-term debt	$522.44M	—	—	—	$383.55M	$583.38M	$580.49M	$376.72M	$372.19M	$367.66M	$363.12M	$293.59M
Total debt	$522.44M	—	—	—	$585.32M	$583.38M	$580.49M	$376.72M	$372.19M	$367.66M	$363.12M	$293.59M
Total liabilities	$704.26M	$691.16M	$767.54M	$772.11M	$775.17M	$788.13M	$779.50M	$570.36M	$571.81M	$554.64M	$572.00M	$490.32M
Shareholders' equity	$870.13M	$892.16M	$879.28M	$749.58M	$778.35M	$798.54M	$757.77M	$727.21M	$693.11M	$653.89M	$671.98M	$712.32M

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$47.58M	$49.10M	$53.24M	$53.92M	$33.13M	$35.46M	$12.01M	$60.83M	$43.69M	$25.68M	$57.46M	$50.07M
Capital expenditures	$1.80M	$2.84M	$1.59M	$4.09M	$2.12M	$8.55M	$2.70M	$3.87M	$218.00K	$2.72M	$1.34M	$3.62M
Free cash flow	$45.79M	$46.27M	$51.65M	$49.83M	$31.01M	$26.91M	$9.31M	$56.96M	$43.47M	$22.96M	$56.12M	$46.45M
Investing cash flow	$8.37M	-$15.53M	-$15.21M	-$52.16M	-$368.00K	-$25.63M	$62.16M	$43.61M	$19.33M	$19.44M	$11.76M	$60.81M
Financing cash flow	-$1.78M	-$2.82M	$24.98M	-$2.85M	-$1.96M	-$2.99M	-$57.51M	-$257.48M	-$51.65M	-$59.40M	-$7.65M	-$69.77M
Share buybacks	$0	—	—	$0	$0	$0	$50.04M	$50.04M	$48.25M	$50.05M	$0	$0
Stock-based compensation	$12.42M	$13.15M	$12.52M	$13.23M	$12.27M	$14.55M	$15.47M	$13.98M	$13.50M	$13.54M	$14.96M	$11.82M
Depreciation & amortization	$18.48M	$18.43M	$18.86M	$20.25M	$21.24M	$21.17M	$27.32M	$21.19M	$21.34M	$21.33M	$21.30M	$19.27M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.